Eliciting Informed Goals of Care in Elderly Patients (ASKMEGOC)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06002113 |
Recruitment Status :
Not yet recruiting
First Posted : August 21, 2023
Last Update Posted : August 21, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Goals of Care Patient Preference End of Life | Other: GOCD Tool Other: Usual care | Not Applicable |
Objectives:
- To determine the impact of facilitated Goals of Care Discussions (GOCDs) on the number of ICU, ventilator, and dialysis days during the index hospitalization (or until death)
- To determine the impact of facilitated GOCDs on the number of hospital, ICU, ventilator, and dialysis days after the index hospitalization until 12 months post-discharge (or until death).
- To determine the impact of facilitated GOCDs on the concordance between documented patient preferences for Life-Sustaining Therapies (LSTs) (during the index hospitalization) and whether these LSTs were received after the index hospitalization until 12 months post-discharge (or until death).
- To determine the impact of facilitated GOCDs on other outcomes including decisional conflict and quality of communication, patient satisfaction with the encounter, and place of death.
- To determine the barriers and facilitators to the implementation of GOCDs.
Design:
A prospective, single-centre, stratified, parallel group, allocation concealed, statistician-masked, randomized, pragmatic, mixed-method, comparative effectiveness trial in hospitalized elderly patients 80 years and older.
Participants:
This study will include all elderly patients admitted to the Royal Victoria Regional Health Centre in Barrie, Ontario, Canada, with an acute medical or surgical diagnosis who fulfill all the inclusion criteria and for whom none of the exclusion criteria exist.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 1200 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Health Services Research |
Official Title: | Assessment of Shared Decision-making Tool for Eliciting Informed Goals of Care in the Hospitalized Elderly (ASKMEGOC): A Randomized Clinical Trial |
Estimated Study Start Date : | September 15, 2023 |
Estimated Primary Completion Date : | October 15, 2024 |
Estimated Study Completion Date : | October 15, 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: GOCD Tool
Intensive care unit-facilitated goals-of-care discussion using web-based shared-decision making software tool
|
Other: GOCD Tool
Web-based tool with 4 components; pre-admission health status; current illness prognosis for hospital survival; in-hospital cardiorespiratory arrest prognosis; values and goals of care |
Active Comparator: usual care
Usual discussions conducted by attending physician with patient
|
Other: Usual care
Attending physicians responsible for GOCD during hospitalization using their usual approaches |
- ICU-related health care utilization [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]total number of ventilator, ICU, and dialysis days
- ICU-related health care utilization [ Time Frame: 12 months after discharge from index hospital admission ]total number of ventilator, ICU, and dialysis days
- Goal-concordant care for ICU-related health care utilization [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]proportion of patients who received goal-concordant care according to resuscitation preferences
- Goal-concordant care for ICU-related health care utilization [ Time Frame: 12 months after discharge from index hospital admission ]proportion of patients who received goal-concordant care according to resuscitation preferences
- Resuscitation level designation [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]proportion of patients with completed resuscitation preferences identified
- Distribution of ICU-related days of health care utilization [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]compare empirical distributions of total days of health care utilization
- Time required to complete GOCD-facilitated discussion [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]Total time required to complete intervention
- Quality of communication [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]assessment of patient perceptions of quality of goals of care discussion
- patient satisfaction with GOCD discussion [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]patient satisfaction with goals of care discussions
- Evaluation of GOCD tool [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]patient's perceptions of quality of web-based tool
- Patient-provider agreement on resuscitation preferences [ Time Frame: From date of randomization until hospital discharge or death in hospital, assessed up to 12 months ]decision concordance between patients and providers
- Death [ Time Frame: From date of randomization until death in hospital or after discharge, assessed up to 12 months ]date and time and place of death during study period
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 80 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Hospitalized patients ≥ 80 years old with an acute medical or surgical condition admitted to any hospital ward
- Duration of admission ≥ 24 hours
- English speaking, or translator present
- Competent patient or substitute decision maker
Exclusion Criteria:
- Treating physician, patient, or substitute decision maker declines
- Documented resuscitation preferences for comfort or supportive care
- New diagnosis of life-limiting illness on this hospital admission, for example, new diagnosis of metastatic cancer
- Clinically unstable, admitted to an intensive care unit, or currently receiving acute life support treatment (mechanical ventilation, acute dialysis, or inotropic/vasopressor support)
- Readmission after index hospitalization
- Pre-existing need for chronic mechanical ventilation (invasive mechanical ventilation via tracheostomy > 90 days) or maintenance dialysis (peritoneal or hemodialysis > 90 days)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06002113
Contact: Giulio DiDiodato, MD PhD | 7057289090 ext 45641 | didiodatog@rvh.on.ca | |
Contact: Kelly Cruise, BHSc | 7057289090 ext 45639 | cruisek@rvh.on.ca |
Principal Investigator: | Giulio DiDiodato, MD PhD | Royal Victoria Regional Health Centre | |
Principal Investigator: | Chris Martin, MD | Royal Victoria Regional Health Centre | |
Principal Investigator: | Doug Austgarden, MD | Royal Victoria Regional Health Centre |
Responsible Party: | Giulio DiDiodato, Chief Research Scientist, Royal Victoria Hospital, Canada |
ClinicalTrials.gov Identifier: | NCT06002113 |
Other Study ID Numbers: |
R22-003 |
First Posted: | August 21, 2023 Key Record Dates |
Last Update Posted: | August 21, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Only upon request, de-identified data may be shared |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Death Pathologic Processes |